Table 2:
Strains | IR dose (cGy) | Number of hCD34+ cells | Time to reconstitution | Functional NK cell development |
---|---|---|---|---|
NSG | 80 | 100k | ≥12 weeks | No |
NOG-IL2 | 250 | 50k | 4 weeks | Yes * |
NOG-IL15 | Unknown | Unknown | Unknown | Unknown |
NSG-IL15 | 80 | 100k | ≥12 weeks | Unknown |
NSG-IL7-IL15 | 150 | 2.5k – 26k | ≥12 weeks | Yes |
SRG | 360 | 100k | ≥12 weeks | No |
SRG-15 | 360 | 100k | ≥12 weeks | Yes * |
NSG-SGM3 | 80 | 50k | 7–8 weeks | Unknown |
MISTRG | 80 or none | 10–50k | 7–8 weeks | Yes * |
BRGSF | 300 | 200k | 8–9 weeks | Yes |
Studies with these three next-generation humanized mouse stains demonstrated NK cell-mediated killing of tumor cells in vivo (MHC class I-deficient tumor cells and/or ADCC).